BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21770028)

  • 1. Critical evaluation of current developmental toxicity testing strategies: a case of babies and their bathwater.
    Carney EW; Ellis AL; Tyl RW; Foster PM; Scialli AR; Thompson K; Kim J
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):395-403. PubMed ID: 21770028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental toxicity testing for safety assessment: new approaches and technologies.
    Knudsen TB; Kavlock RJ; Daston GP; Stedman D; Hixon M; Kim JH
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):413-20. PubMed ID: 21770025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future needs for developmental toxicity testing.
    Makris SL; Kim JH; Ellis A; Faber W; Harrouk W; Lewis JM; Paule MG; Seed J; Tassinari M; Tyl R
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):384-94. PubMed ID: 21922641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental toxicology: new directions workshop: refining testing strategies and study designs.
    Brannen KC; Fenton SE; Hansen DK; Harrouk W; Kim JH; Shuey D
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):404-12. PubMed ID: 22006510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview: developmental toxicology: new directions.
    Shuey D; Kim JH
    Birth Defects Res B Dev Reprod Toxicol; 2011 Oct; 92(5):381-3. PubMed ID: 21770024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modular one-generation reproduction study as a flexible testing system for regulatory safety assessment.
    Vogel R; Seidle T; Spielmann H
    Reprod Toxicol; 2010 Apr; 29(2):242-5. PubMed ID: 19808091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research strategy for developing key information on bromate's mode of action.
    Bull RJ; Cottruvo JA
    Toxicology; 2006 Apr; 221(2-3):135-44. PubMed ID: 16298034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct dosing of preweaning rodents in toxicity testing and research: deliberations of an ILSI RSI Expert Working Group.
    Moser VC; Walls I; Zoetis T
    Int J Toxicol; 2005; 24(2):87-94. PubMed ID: 16036767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge of reproductive and developmental toxicology under REACH.
    Scialli AR
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches: a workshop report.
    van der Laan JW; Chapin RE; Haenen B; Jacobs AC; Piersma A
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):115-23. PubMed ID: 22449444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative experimental approaches for interpreting skeletal findings in safety studies.
    Augustine-Rauch K
    Birth Defects Res B Dev Reprod Toxicol; 2007 Dec; 80(6):497-504. PubMed ID: 18157901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
    Kimmel CA
    Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive safety studies with genistein in rats.
    McClain RM; Wolz E; Davidovich A; Edwards J; Bausch J
    Food Chem Toxicol; 2007 Aug; 45(8):1319-32. PubMed ID: 17433519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical evaluation of developmental and reproductive toxicology in nonhuman primates.
    Faqi AS
    Syst Biol Reprod Med; 2012 Feb; 58(1):23-32. PubMed ID: 22239078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In honor of the Teratology Society's 50th anniversary: The role of Teratology Society members in the development and evolution of in vivo developmental toxicity test guidelines.
    Tyl RW
    Birth Defects Res C Embryo Today; 2010 Jun; 90(2):99-102. PubMed ID: 20544693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.